News

• Notice of Pre-Application Webinar for RFA-AG-24-004 "Estimating the Monetary Costs of Dementia in the United States (U01 Clinical Trial Not Allowed)"
  (NOT-AG-23-002)
  National Institute on Aging

• Notice of Pre-Application Webinar for RFA-AG-24-012 and RFA-AG-24-013 on Postbaccalaureate and Summer Research Programs in AD/ADRD
  (NOT-AG-23-009)
  National Institute on Aging

• Notice of Pre-Application Webinar for RFA-DK-22-038, Pilot Interventions to Integrate Social Care and Medical Care to Improve Health Equity (R01- Clinical Trial Required)
  (NOT-DK-23-014)
  National Institute of Diabetes and Digestive and Kidney Diseases

• Notice of Changes to RFA-ES-23-007 "Exploratory Grants for Climate Change and Health Research Center Development (P20 Clinical Trial Optional)"
  (NOT-ES-23-009)
  National Institute of Environmental Health Sciences

• Notice of Informational Webinar on the NIGMS U-RISE and MARC Programs (T34)
  (NOT-GM-23-037)
  National Institute of General Medical Sciences

• NHLBI Notice of Clarification and Availability of Frequently Asked Questions (FAQs) for RFA-HL-23-008 and RFA-HL-23-009 "NHLBI SBIR Phase IIB Small Market Awards"
  (NOT-HL-23-082)
  National Heart, Lung, and Blood Institute

• Notice of Upcoming Prize Competition Announcement for the TARGETED (Targeted Genome Editor Delivery) Challenge
  (NOT-RM-23-008)
  Office of Strategic Coordination (Common Fund)

• Request for Information (RFI): Inviting comments and suggestions on the development of a EUREKA prize for early prediction of Alzheimer's disease and related dementias (AD/ADRD)
  (NOT-AG-23-012)
  National Institute on Aging

• Request for Information (RFI): Inviting input on use of a term like preaddiction for identifying and intervening in substance misuse and mild/early-stage substance use disorder
  (NOT-DA-23-019)
  National Institute on Drug Abuse
  National Institute on Alcohol Abuse and Alcoholism

Notice of Changes to Funding Opportunities

• Notice to Extend the Expiration Date of PAR-20-309 "Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required)
  (NOT-AG-23-014)
  National Institute on Aging

• Notice to Extend the Expiration Date for PA-20-135, Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)
  (NOT-OD-23-104)
  National Institutes of Health

Notices of Intent to Publish

• Notice of Intent to Publish Funding Opportunity Announcement for Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH) Mechanism (U01 Clinical Trial Optional)
  (NOT-MH-23-195)
  National Institute of Mental Health

• Notice of Intent to Publish Funding Opportunity Announcement for Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH): Data Coordinating Center (U24 Clinical Trial Not Allowed)
  (NOT-MH-23-196)
  National Institute of Mental Health

• Notice of Intent to Publish a Funding Opportunity Announcement for Biotypes of CNS complications in people living with HIV (P01 Clinical Trial Not Allowed)
  (NOT-MH-23-210)
  National Institute of Mental Health
  National Institute on Drug Abuse

• Notice of Intent to Publish a Funding Opportunity for Emergency Medicine Research Career Development Program in the Neurological Sciences (EMRCDP-NS) (K12 - No Independent Clinical Trial Allowed)
  (NOT-NS-23-065)
  National Institute of Neurological Disorders and Stroke

Requests for Proposal

• Notice of Request for Proposals (RFP), Solicitation 75N91023R00034: NATIONAL CANCER INSTITUTE (NCI) SMALL BUSINESS INNOVATION RESEARCH (SBIR) INNOVATIVE CONCEPT AWARD PROGRAM
  (NOT-CA-23-050)
  National Cancer Institute

Notices of Special Interest

• Notice of Special Interest (NOSI): Promoting Health, Safety, and Recovery Training following Declared Disasters in 2022 (Admin Supp Clinical Trial Not Allowed)
  (NOT-ES-23-007)
  National Institute of Environmental Health Sciences

• Notice of Special Interest (NOSI): Availability of Administrative Supplements to IDeA Awards to Fund Team Science Development Projects
  (NOT-GM-23-034)
  National Institute of General Medical Sciences

• Notice of Special Interest (NOSI): Administrative Supplements to Encourage Research in Valvular Heart Disease (CAROL Act)
  (NOT-HL-23-078)
  National Heart, Lung, and Blood Institute

• Notice of Special Interest (NOSI): Administrative Supplements to Support Collaborative HIV/AIDS Research Projects at NIMHD-Funded Research Centers in Minority Institutions (RCMI)
  (NOT-MD-23-007)
  National Institute on Minority Health and Health Disparities
  National Institute of Allergy and Infectious Diseases
  Office of Research on Women's Health

Funding Opportunities

• NIH Administrative Supplements to Recover Losses due to Hurricanes Fiona and Ian Under the Consolidated Appropriations Act, 2023 (Admin Supp Clinical Trial Optional)
  (PA-23-134)
  National Institutes of Health
  Application Receipt Date(s): September 28, 2023
  
  
• Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)
  (PAR-23-122)
  National Institute of General Medical Sciences
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Human Genome Research Institute
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Library of Medicine
  Office of Behavioral and Social Sciences Research
  Office of the Director, NIH
  Office of Research on Women's Health
  Application Receipt Date(s): May 07, 2026
  
  
• Entry-Level Modules (ELM) for Training the Genomics Research Workforce (R25-Clinical Trial Not Allowed)
  (PAR-23-123)
  National Human Genome Research Institute
  National Cancer Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): June 01, 2023
  
  
• Biological Testing Facility (X01 Clinical Trial Not Allowed)
  (PAR-23-128)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): Multiple dates, see announcement.
  
  
• Blood Brain Barrier Response to Antibodies Targeting Beta-Amyloid (R01 - Clinical Trial Not Allowed)
  (PAR-23-140)
  National Institute of Neurological Disorders and Stroke
  National Institute on Aging
  Application Receipt Date(s): June 02, 2023
  
  
• Estimating the Monetary Costs of Dementia in the United States (U01 Clinical Trial Not Allowed)
  (RFA-AG-24-004)
  National Institute on Aging
  Application Receipt Date(s): July 03, 2023
  
  
• Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Real-World Data Platform (U54 Clinical Trial Optional)
  (RFA-AG-24-009)
  National Institute on Aging
  National Institute of Neurological Disorders and Stroke
  Application Receipt Date(s): July 31, 2023
  
  
• Limited Competition: The Health and Retirement Study and Harmonized Cognitive Assessment Protocol (U01 Clinical Trial Not Allowed)
  (RFA-AG-24-010)
  National Institute on Aging
  Application Receipt Date(s): July 02, 2023
  
  
• Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Flaviviridae and Togaviridae (U19 Clinical Trial Not Allowed)
  (RFA-AI-23-019)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): June 08, 2023
  
  
• Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Centers for Bunyavirales, Paramyxoviridae and Picornaviridae (U19 Clinical Trial Not Allowed)
  (RFA-AI-23-020)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): June 08, 2023
  
  
• Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) Network - Coordination and Data Sharing Center (CDSC) (UG3/UH3 Clinical Trial Not Allowed)
  (RFA-AI-23-021)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): June 08, 2023
  
  
• Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit (U24 Clinical Trial Not Allowed)
  (RFA-CA-23-031)
  National Cancer Institute
  Application Receipt Date(s): May 05, 2023
  
  
• NIBIB Biomaterials Network Technology Development Coordinating Center (U24 Clinical Trial Not Allowed)
  (RFA-EB-23-002)
  National Institute of Biomedical Imaging and Bioengineering
  Application Receipt Date(s): May 31, 2023
  
  
• Systematic Review of Clinical Outcome Assessments (COAs) for Communication Brain-Computer Interface Devices (cBCIs) in Amyotrophic Lateral Sclerosis (ALS) (UH2/UH3) Clinical Trials Not Allowed
  (RFA-FD-23-030)
  Food and Drug Administration
  Application Receipt Date(s): May 24, 2023
  
  
• BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)
  (RFA-NS-24-004)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Mental Health
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): January 20, 2026
  
  
• BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)
  (RFA-NS-24-005)
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Eye Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Mental Health
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): January 20, 2026
  
  
• NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
  (RFA-RM-23-004)
  Office of Strategic Coordination (Common Fund)
  Application Receipt Date(s): September 08, 2023